These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
204 related articles for article (PubMed ID: 1495661)
1. Beneficial effect of simvastatin in patients with drug resistant familial hypercholesterolaemia. Lewis-Barned NJ; Ball MJ N Z Med J; 1992 Jul; 105(938):284-6. PubMed ID: 1495661 [TBL] [Abstract][Full Text] [Related]
2. Simvastatin therapy for hypercholesterolaemia in patients with coronary heart disease. French JK; White HD; Greaves SC N Z Med J; 1990 Feb; 103(883):41-3. PubMed ID: 2304688 [TBL] [Abstract][Full Text] [Related]
3. Simvastatin (MK 733) in heterozygous familial hypercholesterolemia: a two-year trial. Leclercq V; Harvengt C Int J Clin Pharmacol Ther Toxicol; 1989 Feb; 27(2):76-81. PubMed ID: 2921098 [TBL] [Abstract][Full Text] [Related]
4. [Effects of simvastatin on atherogenic blood lipid pattern]. Alessandri C; Peverini F; Basili S; Barsi R; Paradiso M; Marotta P; Censi C; Cordova C; Balsano F Recenti Prog Med; 1991 Apr; 82(4):225-9. PubMed ID: 1857842 [TBL] [Abstract][Full Text] [Related]
5. [Effectiveness, tolerance and safety of simvastatin in comparison with bezafibrate in treatment of hypercholesterolemia]. Lechleitner M; Sailer S; Irsigler H; Klein W; Patsch JR Wien Med Wochenschr; 1995; 145(21):577-83. PubMed ID: 8560901 [TBL] [Abstract][Full Text] [Related]
6. Dietary management of patients with familial hypercholesterolaemia treated with simvastatin. Chisholm A; Mann J; Sutherland W; Williams S; Ball M Q J Med; 1992; 85(307-308):825-31. PubMed ID: 1484945 [TBL] [Abstract][Full Text] [Related]
7. Treatment of primary hypercholesterolaemia with simvastatin. New Zealand multicentre evaluation. Lintott CJ; Scott RS; Sharpe DN; Nye ER; Charleson H; French JK; White HD; Reuben S; Maling TJ; Lewis GR Med J Aust; 1991 Oct; 155(7):433-6. PubMed ID: 1921811 [TBL] [Abstract][Full Text] [Related]
8. A one-year multicentre study of simvastatin in the treatment of hypercholesterolaemia. UK and Eire Simvastatin Study Group. Br J Clin Pract; 1994; 48(5):231-5. PubMed ID: 7917813 [TBL] [Abstract][Full Text] [Related]
9. The effect of simvastatin treatment on the low-density lipoprotein subfraction profile and composition in familial hypercholesterolaemia. de Graaf J; Demacker PN; Stalenhoef AF Neth J Med; 1993 Dec; 43(5-6):254-61. PubMed ID: 8107933 [TBL] [Abstract][Full Text] [Related]
10. [Simvastatin in the treatment of familial hypercholesterolemia]. Ceska R; Sobra J; Procházková R; Kvasilová M Cas Lek Cesk; 1995 May; 134(10):310-3. PubMed ID: 7788650 [TBL] [Abstract][Full Text] [Related]
11. Comparison of the short term efficacy and tolerability of lovastatin and simvastatin in the management of primary hypercholesterolemia. Frohlich J; Brun LD; Blank D; Campeau L; Crockford P; Curnew G; Dafoe W; Davignon J; Dufour R; Emery G Can J Cardiol; 1993 Jun; 9(5):405-12. PubMed ID: 8348392 [TBL] [Abstract][Full Text] [Related]
12. [HMG-CoA reductase inhibitors in familial hypercholesterolemia. Therapy with simvastatin alone and in combination with cholestyramine in low dosage; a report of 2 years experiences]. Geisel J; Oette K; Burrichter H Fortschr Med; 1990 Feb; 108(4):71-2, 75-6. PubMed ID: 2312032 [TBL] [Abstract][Full Text] [Related]
13. The effects of simvastatin on serum lipoproteins in severe hypercholesterolaemia. Mol MJ; Stuyt PM; Demacker PN; Stalenhoef AF Neth J Med; 1990 Apr; 36(3-4):182-90. PubMed ID: 2355995 [TBL] [Abstract][Full Text] [Related]
14. [Simvastatin in the treatment of hypercholesterolemia]. Cigala O; Pancallo MT; Della Valle M; Marasco A; Malarbi AL Clin Ter; 1991 Jun; 137(5):333-7. PubMed ID: 1832606 [TBL] [Abstract][Full Text] [Related]
15. Comparison of simvastatin and cholestyramine in the treatment of primary hypercholesterolaemia. O'Brien RC; Simons LA; Clifton P; Cooper ME; Jennings GL; Jerums G; Nestel PJ; Sullivan D Med J Aust; 1990 May; 152(9):480-3. PubMed ID: 2199801 [TBL] [Abstract][Full Text] [Related]
16. Effect of simvastatin in familial hypercholesterolemia on the affinity of electronegative low-density lipoprotein subfractions to the low-density lipoprotein receptor. Benítez S; Ordóñez-Llanos J; Franco M; Marín C; Paz E; López-Miranda J; Otal C; Pérez-Jiménez F; Sánchez-Quesada JL Am J Cardiol; 2004 Feb; 93(4):414-20. PubMed ID: 14969613 [TBL] [Abstract][Full Text] [Related]
17. Combined bezafibrate and simvastatin treatment for mixed hyperlipidaemia. Kehely A; MacMahon M; Barbir M; Wray R; Hunt BJ; Prescott RJ; Thompson GR QJM; 1995 Jun; 88(6):421-7. PubMed ID: 7648234 [TBL] [Abstract][Full Text] [Related]
18. Effects of simvastatin and cholestyramine in familial and nonfamilial hypercholesterolemia. Multicenter Group I. Stein E; Kreisberg R; Miller V; Mantell G; Washington L; Shapiro DR Arch Intern Med; 1990 Feb; 150(2):341-5. PubMed ID: 2405804 [TBL] [Abstract][Full Text] [Related]
19. [Evaluation of tolerance, efficacy and safety of 3-year simvastatin use in the treatment of primary hypercholesterolemia]. Darioli R; Bovet P; Brunner HR; Bercher L Schweiz Med Wochenschr; 1990 Jan; 120(4):85-91. PubMed ID: 2305221 [TBL] [Abstract][Full Text] [Related]
20. Simvastatin in the effective reduction of plasma lipoprotein levels in familial dysbetalipoproteinemia (type III hyperlipoproteinemia). Stuyt PM; Mol MJ; Stalenhoef AF; Demacker PN; Van 't Laar A Am J Med; 1990 Jan; 88(1N):42N-45N. PubMed ID: 2368763 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]